A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis

A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis Potent inhibitors of the MAP kinase p38 Discovery of a new class of p38 kinase inhibitors The design and synthesis of novel α-ketoamide-based p38 MAP kinase inhibitors Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase Docking, synthesis and pharmacological activity of novel urea-derivatives designed as p38 MAPK inhibitors Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase Design, Synthesis, and Biological Evaluation of Novel Disubstituted Dibenzosuberones as Highly Potent and Selective Inhibitors of p38 Mitogen Activated Protein Kinase Optimization of α-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site